Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
10.51 AUD | -2.95% | -2.50% | -12.42% |
Mar. 21 | Knight Therapeutics Reports Fourth Quarter Results | MT |
Feb. 29 | Knight Therapeutics Announces Launch of Minjuvi in Brazil | MT |
Sales 2024 * | 993M 637M | Sales 2025 * | 1.05B 671M | Capitalization | 1.48B 950M |
---|---|---|---|---|---|
Net income 2024 * | 101M 64.8M | Net income 2025 * | 117M 75.07M | EV / Sales 2024 * | 1.86 x |
Net Debt 2024 * | 368M 236M | Net Debt 2025 * | 327M 210M | EV / Sales 2025 * | 1.73 x |
P/E ratio 2024 * |
14.8
x | P/E ratio 2025 * |
12.7
x | Employees | 1,996 |
Yield 2024 * |
3.98% | Yield 2025 * |
4.62% | Free-Float | 95.34% |
Latest transcript on GUD Holdings Limited
1 day | -2.95% | ||
1 week | -2.50% | ||
Current month | -10.93% | ||
1 month | -7.81% | ||
3 months | -11.16% | ||
6 months | -2.78% | ||
Current year | -12.42% |
Managers | Title | Age | Since |
---|---|---|---|
Graeme Whickman
CEO | Chief Executive Officer | - | 18-09-30 |
Director of Finance/CFO | - | 11-12-31 | |
Anne Mustow
IRC | Investor Relations Contact | - | 23-07-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
John Pollaers
BRD | Director/Board Member | 62 | 21-06-22 |
Graeme Billings
CHM | Chairman | 68 | 11-12-19 |
David Robinson
BRD | Director/Board Member | 75 | 11-12-19 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.01% | 773 M€ | -.--% | - | |
0.01% | 10 M€ | -3.35% | - | |
0.00% | 7 M€ | -0.18% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-04-19 | 10.51 | -2.95% | 249,709 |
24-04-18 | 10.83 | +1.03% | 188,777 |
24-04-17 | 10.72 | +2.39% | 338,110 |
24-04-16 | 10.47 | -2.15% | 252,863 |
24-04-15 | 10.7 | -0.74% | 193,138 |
Delayed Quote Australian S.E., April 19, 2024 at 02:10 am EDT
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-12.42% | 983M | |
+32.56% | 54.92B | |
+31.44% | 21.28B | |
-22.39% | 18.9B | |
+23.03% | 16.04B | |
-1.05% | 15.48B | |
-15.12% | 13.76B | |
-18.93% | 13.54B | |
+32.80% | 12.28B | |
+23.01% | 10.63B |
- Stock Market
- Equities
- GUD Stock